This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation | MicrobiomeTrials
← Back to trials NCT05723926
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-01-09Est. Completion: 2028-12-20
Enrollment target: 2,000 participantsLocations Mercyhealth Javon Bea Hospital - Riverside, Rockford, Illinois, United States Weill Cornell Medical Center, New York, New York, United States Erlanger Medical Center, Chattanooga, Tennessee, United States Methodist University Hospital, Memphis, Tennessee, United States Baptist Memorial Hospital-Memphis, Memphis, Tennessee, United States Hamilton General Hospital, Hamilton, Canada, Canada University Hospital, London, Ontario, Canada Other microbiome trials you might be interested in Chronic Kidney Disease
This is a population-based retrospective, new-user, active comparator cohort study assessing whether initiating a new ou…
Multiple Locations Completed Dec 1, 2025
Atrial Fibrillation
The objective of this study is to determine whether participation in an 8-week structured cardiac rehabilitation program…
Paramus, United States Completed Feb 27, 2025
Diagnostic/Monitoring Devices Related to Adverse Incidents
Atrial Fibrillation (AF)
Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main prob…
Calgary, Canada Est. completion Dec 31, 2026